AngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary

AngioDynamics

08/10/2026 14:33

AngioDynamics, Inc. ANGO.OQ reported a quarterly adjusted loss of 4 cents​​ per share for the quarter ended August 31, higher than the same quarter last year, when the company reported EPS of -10 cents.  The mean expectation of three analysts for the quarter was for a loss of 11 cents per share. Wall Street expected results to range from -13 cents to -10 cents per share.
Revenue rose 6.9% to $80.92 million from a year ago; analysts expected $80.50 million. 
AngioDynamics, Inc.'s reported EPS for the quarter was a loss of 17 cents​.
The company reported a quarterly loss of $7.1 million.
AngioDynamics, Inc. shares had fallen by 7.7% this quarter and gained 10.5% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 17.2% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for AngioDynamics, Inc. is $19.50, about 27.2% above its last closing price of $14.19
This summary was machine generated from LSEG data October 8 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Aug. 31 2026 
-0.11
-0.04
Beat
May. 31 2026 
-0.09
-0.07
Beat
Feb. 28 2026 
-0.11
0.02
Beat
Nov. 30 2025 
-0.10
0.00
Beat